N/A
Manufactured by Actelion Pharmaceuticals US, Inc.
96,284 FDA adverse event reports analyzed
Last updated: 2026-04-14
SELEXIPAG is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Actelion Pharmaceuticals US, Inc.. The most commonly reported adverse reactions for SELEXIPAG include HEADACHE, DIARRHOEA, DYSPNOEA, NAUSEA, FATIGUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SELEXIPAG.
Out of 24,800 classified reports for SELEXIPAG:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 96,284 FDA FAERS reports that mention SELEXIPAG. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include HEADACHE, DIARRHOEA, DYSPNOEA, NAUSEA, FATIGUE, DEATH. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Actelion Pharmaceuticals US, Inc. in connection with SELEXIPAG. Always verify the specific product and NDC with your pharmacist.